Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Remote Patient Monitoring (RPM) Market worth $207.5 billion by 2028

 



(PharmaNewsWire.Com, May 22, 2024 ) The report "Remote Patient Monitoring Market by Product (Software, Services, Devices, Cardiology, Neurological, BP Monitors, Neonatal, Weight, Temperature, Neuro) End user (Providers, Hospitals, Clinics, Home care, Patients, Payers) - Global Forecast to 2028", is projected to reach USD 207.5 billion by 2028 from USD 71.9 billion in 2023, at a CAGR of 23.6% between 2023 and 2028.

Download PDF Brochure :-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=77155492

The growth of the remote patient monitoring (RPM) market is being driven by the aging population, the need to expand healthcare access, the ability of RPM to reduce the burden on medical resources, and rising investments in telehealth and remote patient monitoring. However, informal usage of social meda rsising instance of healthcare fraud and regulatory variations across regions could restrain market growth during the forecast period.

Software and services is expected to register the highest CAGR during the forecast period

Based on the product, the remote patient monitoring market is segmented into software & services and devices. The software and services segment is expected to register the highest CAGR during the forecast period . The highest growth of this segment is because the RPM services are growing rapidly as more RPM programs are being reimbursed and more people have chronic illnesses.

Diabetes segment accounted for the largest share of the remote patient monitoring market during the forecast period.

Based on application, the global remote patient monitoring market is broadly segmented into oncology, cardiovascular diseases, diabetes, sleep disorders, weight management and fitness monitoring. The diabetes segment accounted for the largest share of the global market during the forecast period. This can be attributed to the high prevalence of diabetes, reimbursement for RPM programs, advancements in RPM technology, and need for continuous monitoring.

Providers segment accounted for the largest share of the remote patient monitoring market during the forecast period.

Based on end users, the global remote patient monitoring market is broadly segmented into providers, payers, patients, and other end users. The proivders segment accounted for the largest share of the remote patient monitoring market during the forecast period. The large share of the providers can be attributed to the increase in telehealth and telemedicine adoption by physician groups, hospitals, clinics, and other healthcare facilities, advancements in telehealth monitoring devices, and increased tele-specialty services offered by the providers.

Asia Pacific is expected to register the highest CAGR during the forecast period

In 2022, Asia Pacific is expected to register the highest CAGR during the forecast period. This can be attributed to the prevalence of chronic diseases, subsequent overcrowding in hospitals, rising geriatric population, growth opportunities for advanced internet-based platforms in the RPM, favourable government policies, the rising need to curtail healthcare expenditure, and increasing consumer awareness of health-related issues in RoAPAC (Rest of Asia-pacific) countries.

Request for Sample Pages:-https://www.marketsandmarkets.com/requestsampleNew.asp?id=77155492

Prominent players in the remote patient monitoring market are Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), GE Healthcare (US), Oracle (US), Siemens Healthineers AG (Germany), Omron Healthcare (Japan), Boston Scientific Corporation (US), Abbott Laboratories (US), Clear Arch, Inc (US), Vivify Health, Inc. (US), Alten Calsoft Labs (France), Bio-Beat (Israel), VitalConnect (US), VivaLNK Inc. (US), Bardy Diagnsotics, Inc. (US), Biotronik SE & Co. KG (Germany), Brook Inc. (US), Blue Spark Technology (US), Welch Allyn (US), Health Beats (Singapore), Alive Cor, Inc. (US), TytoCare Ltd. (US), Teledoc Health Inc. (US), and iRhythm Technologies (US).

MarketsandMarkets™

Mr. Aashish Mehra

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC